Emerging therapeutic agents for lung cancer

Por Dholaria, Bhagirathbhai, Hammond, William, Shreders, Amanda, Lou, Yanyan
Publicado no J Hematol Oncol (2016)

ZNF277 regulates ovarian cancer cell proliferation and invasion through inhibition of PTEN

Por Liu, Zhengling, Xu, Zonglan, Tian, Yonghui, Yan, Hua, Lou, Yanyan
Publicado no Onco Targets Ther (2019)

Cancer immunotherapy beyond immune checkpoint inhibitors

Por Marin-Acevedo, Julian A., Soyano, Aixa E., Dholaria, Bhagirathbhai, Knutson, Keith L., Lou, Yanyan
Publicado no J Hematol Oncol (2018)

Cost Effectiveness of Pembrolizumab vs. Standard-of-Care Chemotherapy as First-Line Treatment for Metastatic NSCLC that Expresses High Levels of PD-L1 in the United States

Por Huang, Min, Lou, Yanyan, Pellissier, James, Burke, Thomas, Liu, Frank Xiaoqing, Xu, Ruifeng, Velcheti, Vamsidhar
Publicado no Pharmacoeconomics (2017)

Immunogenicity of Del19 EGFR mutations in Chinese patients affected by lung adenocarcinoma

Por Pan, Deng, Zhou, Dapeng, Cai, Weijing, Wu, Weibo, Tan, Wen Ling, Zhou, Caicun, Lou, Yanyan
Publicado no BMC Immunol (2019)

Next generation of immune checkpoint therapy in cancer: new developments and challenges

Por Marin-Acevedo, Julian A., Dholaria, Bhagirathbhai, Soyano, Aixa E., Knutson, Keith L., Chumsri, Saranya, Lou, Yanyan
Publicado no J Hematol Oncol (2018)

Dendritic Cells Strongly Boost the Antitumor Activity of Adoptively Transferred T Cells In vivo

Por Lou, Yanyan, Wang, Gang, Lizée, Gregory, Kim, Grace J., Finkelstein, Steven E., Feng, Chiguang, Restifo, Nicholas P., Hwu, Patrick
Publicado em 2004

Post-operative radiation therapy in locally advanced non-small cell lung cancer and the impact of sequential versus concurrent chemotherapy

Por Waddle, Mark R., Ko, Stephen, Johnson, Margaret M., Lou, Yanyan, Miller, Robert C., Harrell, Anna C., Trifiletti, Daniel M.
Publicado no Transl Lung Cancer Res (2018)

Emerging therapeutic agents for advanced non-small cell lung cancer

Por Chen, Ruqin, Manochakian, Rami, James, Lauren, Azzouqa, Abdel-Ghani, Shi, Huashan, Zhang, Yan, Zhao, Yujie, Zhou, Kexun, Lou, Yanyan
Publicado no J Hematol Oncol (2020)

PD-1 BLOCKADE ENHANCES T CELL MIGRATION TO TUMORS BY ELEVATING IFN-γ INDUCIBLE CHEMOKINES

Por Peng, Weiyi, Liu, Chengwen, Xu, Chunyu, Lou, Yanyan, Chen, Jieqing, Yang, Yan, Yagita, Hideo, Overwijk, Willem W., Lizée, Gregory, Radvanyi, Laszlo, Hwu, Patrick
Publicado em 2012

Transduction of Tumor-Specific T Cells with CXCR2 Chemokine Receptor Improves Migration to Tumor and Antitumor Immune Responses

Por Peng, Weiyi, Ye, Yang, Rabinovich, Brian A., Liu, Chengwen, Lou, Yanyan, Zhang, Minying, Whittington, Mayra, Yang, Yan, Overwijk, Willem W., Lizée, Gregory, Hwu, Patrick
Publicado em 2010

Agonistic Antibody to CD40 Boosts the Antitumor Activity of Adoptively Transferred T Cells In Vivo

Por Liu, Chengwen, Lewis, Carol M., Lou, Yanyan, Xu, Chunyu, Peng, Weiyi, Yang, Yan, Gelbard, Alexander H., Lizée, Gregory, Zhou, Dapeng, Overwijk, Willem W., Hwu, Patrick
Publicado em 2012

Case Report: Germline Mutation of T790M and Dual/Multiple EGFR Mutations in Patients with Lung Adenocarcinoma

Por Lou, Yanyan, Pecot, Chad V., Tran, Hai T., DeVito, Vikki J., Tang, Xi Ming, Heymach, John, Luthra, Raja, Wistuba, Ignacio I., Zuo, Zhuang, Tsao, Anne S.
Publicado no Clin Lung Cancer (2015)

ANTI-TUMOR ACTIVITY MEDIATED BY CpG: THE ROUTE OF ADMINISTRATION IS CRITICAL

Por Lou, Yanyan, Liu, Chengwen, Lizée, Gregory, Peng, Weiyi, Xu, Chunyu, Ye, Yang, Rabinovich, Brian A., Hailemichael, Yared, Gelbard, Alexander, Zhou, Dapeng, Overwijk, Willem W., Hwu, Patrick
Publicado no J Immunother (2011)

Peripheral blood biomarkers correlate with outcomes in advanced non-small cell lung Cancer patients treated with anti-PD-1 antibodies

Por Soyano, Aixa E., Dholaria, Bhagirathbhai, Marin-Acevedo, Julian A., Diehl, Nancy, Hodge, David, Luo, Yan, Manochakian, Rami, Chumsri, Saranya, Adjei, Alex, Knutson, Keith L., Lou, Yanyan
Publicado no J Immunother Cancer (2018)

Interferon-α enhances peptide vaccine-induced CD8(+) T cell numbers, effector function, and anti-tumor activity

Por Sikora, Andrew G., Jaffarzad, Nina, Hailemichael, Yared, Gelbard, Alexander, Stonier, Spencer W., Schluns, Kimberly S., Frasca, Loredana, Lou, Yanyan, Liu, Chengwen, Andersson, Helen A., Hwu, Patrick, Overwijk, Willem W.
Publicado em 2009

Molecular basis of antibody binding to mucin glycopeptides in lung cancer

Por QU, JIN, YU, HONGTAO, LI, FENGE, ZHANG, CHUNLEI, TRAD, AHMAD, BROOKS, CORY, ZHANG, BIN, GONG, TING, GUO, ZHI, LI, YUNSEN, RAGUPATHI, GOVIND, LOU, YANYAN, HWU, PATRICK, HUANG, WEI, ZHOU, DAPENG
Publicado no Int J Oncol (2015)

Survival trends among non‐small‐cell lung cancer patients over a decade: impact of initial therapy at academic centers

Por Lou, Yanyan, Dholaria, Bhagirathbhai, Soyano, Aixa, Hodge, David, Cochuyt, Jordan, Manochakian, Rami, Ko, Stephen J., Thomas, Mathew, Johnson, Margaret M., Patel, Neal M., Miller, Robert C., Adjei, Alex A., Ailawadhi, Sikander
Publicado no Cancer Med (2018)

Plasmacytoid dendritic cells induce NK cell–dependent, tumor antigen–specific T cell cross-priming and tumor regression in mice

Por Liu, Chengwen, Lou, Yanyan, Lizée, Gregory, Qin, Hong, Liu, Shujuan, Rabinovich, Brian, Kim, Grace J., Wang, Yi-Hong, Ye, Yang, Sikora, Andrew G., Overwijk, Willem W., Liu, Yong-Jun, Wang, Gang, Hwu, Patrick
Publicado em 2008

Effects of Age and Immune Landscape on Outcome in HER2-positive Breast Cancer in the NCCTG N9831 (Alliance) and NSABP B-31 (NRG) Trials

Por Chumsri, Saranya, Serie, Daniel J., Li, Zhuo, Pogue-Geile, Katherine L., Soyano-Muller, Aixa E., Mashadi-Hossein, Afshin, Warren, Sarah, Lou, Yanyan, Colon-Otero, Gerardo, Knutson, Keith L., Perez, Edith A., Moreno-Aspitia, Alvaro, Thompson, E. Aubrey
Publicado no Clin Cancer Res (2019)